Dr. Mohamad R. Alzein, MD

Dr. Alzein practices at Advanced Urgent Care - Orland Park in Orland Park, Illinois.

Dr. Alzein's NPI, 1902900319, was assigned on September 8, 2006. Dr. Alzein graduated from Damascus University Faculty of Medicine in 1990.

Dr. Alzein's primary practice is Advanced Urgent Care - Orland Park, at 10 Orland Square Dr, Orland Park, IL 60462. The practice phone is (708) 448-8913.

Dr. Alzein's primary practice is Advanced Urgent Care - Orland Park in Orland Park, Illinois. Dr. Alzein is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Advanced Urgent Care. Dmand AI also links Dr. Alzein to 2 more hospitals, 2 home health agencies, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Alzein's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alzein practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alzein's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Alzein is board certified in internal medicine by the American Board of Internal Medicine. Dr. Alzein has a license on file in Illinois.

Dmand AI lists acid reflux, acute kidney failure, acute sinusitis, acute skin infection, adjustment disease, alzheimer's disease, aneurysm and ankle or foot injury among the conditions Dr. Alzein treats.

CMS data shows 7,809 Medicare services from Dr. Alzein across 39 procedure codes in 2024, for 356 Medicare patients. Medicare paid $140,446 for them. Every service was in an office.

CMS counts 356 Medicare patients who saw Dr. Alzein in 2024. The largest group is 65 to 74, with 149 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alzein's median patient age at 47, with 52% women.

In 2024, Dr. Alzein wrote 3,751 Medicare Part D claims for 411 patients. 88% of them were for generic drugs. CMS names the drug for 3,162 of them, across 80 drugs with 11 or more claims each, at $156,987 in total drug cost. In 2023, CMS named 3,353 claims across 86 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Alzein for performance year 2024, reported individually. Dr. Alzein accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Alzein in 2023. The most frequent topics are Allografts. Dr. Alzein's most frequent co-authors are Brian J. Cole, MD, Azad Duke Darbandi and Johnathon Robert McCormick, MD.

CMS Open Payments shows 6 general payments to Dr. Alzein from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Solventum Corporation paid the most, $82.

Dr. Alzein graduated from Damascus University Faculty of Medicine in 1990.

Dr. Alzein is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.